Charles E Massie

Charles E Massie

UNVERIFIED PROFILE

Are you Charles E Massie?   Register this Author

Register author
Charles E Massie

Charles E Massie

Publications by authors named "Charles E Massie"

Are you Charles E Massie?   Register this Author

22Publications

735Reads

30Profile Views

Methods to Identify Chromatin-Bound Protein Complexes: From Genome-Wide to Locus-Specific Approaches.

Authors:
Charles E Massie

Methods Mol Biol 2016 ;1443:139-50

Li Ka Shing Centre, Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, CB2 0RE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-3724-0_9DOI Listing
November 2017

The importance of DNA methylation in prostate cancer development.

J Steroid Biochem Mol Biol 2017 02 24;166:1-15. Epub 2016 Apr 24.

Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge, UK. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09600760163010
Publisher Site
http://dx.doi.org/10.1016/j.jsbmb.2016.04.009DOI Listing
February 2017

Choline Kinase Alpha as an Androgen Receptor Chaperone and Prostate Cancer Therapeutic Target.

J Natl Cancer Inst 2016 May 11;108(5). Epub 2015 Dec 11.

Affiliations of authors:Cancer Research UK Cambridge Institute, University of Cambridge , Cambridge, UK (MA, CEM, NP, HIZ, AQ, AB, SM, BM, CE, SL, SW, VRZ, GS, RR, HM, AGL, CD, CT, AL, RS, JY, RS, JSC, JRG, ST, DEN); School of Medical Sciences, University of Aberdeen , Aberdeen, UK (FO, IJM); Department of Pathology, Addenbrooke's Hospital , Cambridge, UK (AYW, NS); Institute of Human Genetics, Jena University Hospital , Jena , Germany (ME, KL, WH, AB); Dame Roma Mitchell Cancer Research Laboratories, School of Medicine, Faculty of Health Sciences, University of Adelaide , Australia (LAS, WDT); Freemasons Foundation Centre for Men's Health, School of Medicine, Faculty of Health Sciences, University of Adelaide , Australia (LAS, WDT); Diatherix , Huntsville, AL (EG); Masonic Cancer Center, University of Minnesota , Minneapolis, MN (SMD); The Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia , Vancouver BC , Canada (PSR); Centre for Molecular Medicine Norway, Nordic EMBL Partnership, University of Oslo and Oslo University Hospital , Oslo , Norway (IGM); Department of Cancer Prevention, Institute of Cancer Research and Department of Urology, Oslo University Hospital , Oslo , Norway (IGM); Prostate Cancer UK/Movember Centre of Excellence, Queens University , Belfast , UK (IGM); Department of Oncology, Addenbrooke's Hospital , Cambridge, UK (MA, DEN).

View Article

Download full-text PDF

Source
http://jnci.oxfordjournals.org/content/108/5/djv371.full.pdf
Web Search
http://jnci.oxfordjournals.org/lookup/doi/10.1093/jnci/djv37
Publisher Site
http://dx.doi.org/10.1093/jnci/djv371DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849803PMC
May 2016

STAT1 activation in association with JAK2 exon 12 mutations.

Haematologica 2016 Jan 3;101(1):e15-9. Epub 2015 Dec 3.

Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, UK Department of Haematology, Addenbrooke's Hospital, UK Department of Haematology, University of Cambridge, Cambridge, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.128546DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697901PMC
January 2016

HES5 silencing is an early and recurrent change in prostate tumourigenesis.

Endocr Relat Cancer 2015 Apr 5;22(2):131-44. Epub 2015 Jan 5.

Cancer Research UK Cambridge InstituteUniversity of Cambridge, Cambridge, CB2 0RE, UKDivision of Genetics and EpidemiologyThe Institute of Cancer Research, Sutton, UKDepartment of Biological Sciences and School of MedicineUniversity of East Anglia, Norwich, UKRoyal Marsden NHS Foundation TrustLondon and Sutton, UKDepartments of PathologyUrologySurgical OncologyAddenbrooke's Hospital, Hills Road, Cambridge, UK

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-14-0454DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335379PMC
April 2015

Effect of mutation order on myeloproliferative neoplasms.

N Engl J Med 2015 Feb;372(7):601-612

Cambridge Institute for Medical Research and Wellcome Trust-Medical Research Council Stem Cell Institute (C.A.O., D.G.K., J.N., Y.S., J.G., E.J.B., C.E.M., A.L.G., D.D., A.R.G.) and Department of Hematology (C.A.O., D.G.K., J.N., Y.S., J.G., E.J.B., C.E.M., A.L.G., D.D., G.S.V., P.J.C., A.R.G.), University of Cambridge, Department of Haematology, Addenbrooke's Hospital (C.A.O., J.N., J.G., E.J.B., A.L.G., G.S.V., P.J.C., A.R.G.), Wellcome Trust Sanger Institute (D.C.W., E.P., G.S.V., P.J.C.), and Cancer Research U.K. Cambridge Institute, Li Ka Shing Centre (S.M.), Cambridge, and Guy's and St. Thomas' National Health Service Foundation Trust, Guy's Hospital, London (C.N.H.) - all in the United Kingdom; Dipartimento di Medicina Sperimentale e Clinica, University of Florence, Florence, Italy (P.G., A.V.); Departments of Pathology (B.B.) and Hematology (C.B.), Hospital del Mar, Barcelona; and the Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany (K.D.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1412098DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660033PMC
February 2015

Nongenetic stochastic expansion of JAK2V617F-homozygous subclones in polycythemia vera?

Blood 2014 Nov;124(22):3332-4

Cambridge Institute for Medical Research and Wellcome Trust/Medical Research Council, Stem Cell Institute and Department of Haematology, University of Cambridge, Cambridge, United Kingdom Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-09-603043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239339PMC
November 2014

Mapping protein-DNA interactions using ChIP-sequencing.

Methods Mol Biol 2012 ;809:157-73

CRUK Cambridge Research Institute, Department of Haematology, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-61779-376-9_11DOI Listing
March 2012

Global identification of androgen response elements.

Methods Mol Biol 2011 ;776:255-73

Cancer Research UK, Cambridge Research Institute, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-61779-243-4_15DOI Listing
November 2011

Chromatin immunoprecipitation (ChIP) methodology and readouts.

Methods Mol Biol 2009 ;505:123-37

Uro-Oncology Research Group, Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-60327-575-0_7DOI Listing
February 2009

ChIPping away at gene regulation.

EMBO Rep 2008 Apr;9(4):337-43

Uro-Oncology Research Group, CRUK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/embor.2008.44DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2288763PMC
April 2008

New androgen receptor genomic targets show an interaction with the ETS1 transcription factor.

EMBO Rep 2007 Sep 17;8(9):871-8. Epub 2007 Aug 17.

Uro-Oncology Research Group, Department of Oncology, University of Cambridge, Cancer Research UK Cambridge, Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.embor.7401046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950328PMC
September 2007

Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression.

Cancer Res 2003 Dec;63(24):8648-55

Cancer Research UK, Edinburgh Oncology Unit, University of Edinburgh Cancer Research Centre, Edinburgh, Scotland, United Kingdom.

View Article

Download full-text PDF

Source
December 2003

OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.

Nat Genet 2003 Jul;34(3):337-43

Cancer Research UK Edinburgh Oncology Unit, University of Edinburgh Cancer Research Centre, Crewe Road South, Edinburgh EH4 2XR, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng1183DOI Listing
July 2003